Fc-engineering significantly improves the recruitment of immune effector cells by anti-ICAM-1 antibody MSH-TP15 for myeloma therapy.

This tendency of being more effective than the wt IgG1 mAb was also seen at 1 mg/kg doses, although differences did not reach statistical significance ( P =0.12; Figure 5C ).

also in 111,027 other papers